Moderna stock is trading higher Wednesday afternoon, lifted by positive sentiment across the pharmaceutical sector.

Moderna, Inc. (NASDAQ:MRNA) ranks among the best biotech stocks to buy. Following solid trial results for Moderna, Inc. (NASDAQ:MRNA)’s refrigerator-stable COVID-19 vaccine, Brookline Capital Markets ...

The company's equity performance has been challenging throughout the year. Even after Wednesday's substantial advance, the stock remains down 37% year-to-date. Moderna's most recent quarterly report ...

How is SPY stock faring? The SPDR S&P 500 ETF Trust ($SPY) is up 0.97% over the past five days and has gained about 14.23% year-to-date. According ...

S&P 500 hits record high as US shutdown starts. Traders bet on short duration and Fed rate cuts, driving gains in health and tech stocks.

Dow turns positive and S&P 500 trims losses as traders focus on Fed rate cut bets and soft ADP payroll data. Despite shutdown headlines, markets remained stable as traders priced in a limited economic ...

Canada's commodity-heavy main stock index rose on Wednesday, led by materials, while investors assessed a partial U.S. government shutdown that threatened to delay key jobs data and potentially cloud ...

Nike trades higher after the sneaker and athletic apparel company’s quarterly earnings beat Wall Street estimates.

The win streak continued for stocks in Toronto Wednesday, with health-care and resource issues supplying huge shoulders. The TSX gained 84.86 points to greet Wednesday’s closing bell at 30,107.67 The ...

The main US stock indexes declined on Wednesday as investors digested soft private payrolls data, while a federal government shutdown risked delaying economic data, heightening the uncertainty around ...

Intel shares jump 6% amid early-stage talks with AMD for chip production. US manufacturing grows in September but slows; exports and demand weaken. Government shutdown continues; Trump administration ...

Health care stocks rallied after Trump struck a drug pricing deal with Pfizer, offering major discounts and pausing pharma tariffs.